ER pain study pulled before it even started
NCT ID NCT07344350
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to compare an oral morphine tablet to a nasal spray painkiller (sufentanil) for treating severe acute pain in emergency departments. It planned to enroll adults with severe pain, measuring pain levels 30 minutes after treatment. However, the study was withdrawn before any participants were enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Morphine sulfate (oral) and sufentanil (intranasal)
- What this could lead to
- If successful, it could show that a simple oral painkiller works as well as a nasal spray for severe pain in the ER.
- What could go wrong
- The study was withdrawn before any patients were enrolled, so no results are available. It is unclear if the approach is safe or effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Sélestat
Sélestat, Bas-Rhin, 67600, France
-
Hôpital Emile Muller
Mulhouse, Haut-Rhin, 68100, France